A female patient with obesity will soon begin treatment with orlistat. The nurse should teach the patient that
A) there will be fat present in her stools.
B) her appetite will decline over the next 48 hours.
C) she will have to increase her fiber intake.
D) she will need to temporarily eliminate fats from her diet.
A
Feedback:
Fatty stools are a notable adverse effect of orlistat. This drug does not reduce appetite. A reduced-fat diet may be of benefit, but it is not necessary to wholly eliminate fats from the diet.
You might also like to view...
If you give two tablets labeled 0.6 mg, what is the total dosage you will administer?
What will be an ideal response?
The HIV-infected patient who has just seroconverted says he just cannot take all those confusing, expensive antiretroviral (ART) medications. He says he still feels fine, anyway. What should the nurse keep in mind when counseling this patient?
a. Resumption of the ART later in the disease is just as effective b. Adherence to the ART protocol is essential to the success of the treatment c. Cessation of the ART may prevent the emergence of a resistant strain of HIV d. Once ART is initiated it cannot be restarted in the same patient
A client with bipolar disorder is having a disturbed thought process. Which of the following nursing interventions can help the client to be oriented and accurately perceive circumstances surrounding admission?
A) Provide ample information. B) Listen and supporting the client when in delusion. C) Reduce distracting stimuli. D) Offer a large-muscle activity.
The patient in the emergency department experienced an acute myocardial infarction (MI) 8 hours ago. The nurse is administering reteplase (Retavase) intravenously (IV). The patient asks the nurse what is being done. What is the best response by the nurse?
1. "This medicine is widening the arteries in your heart so they can get more oxygen." 2. "This medication is dissolving the clot that is causing your heart attack." 3. "This medicine is thinning your blood so more clots will not develop." 4. No response is indicated; the patient is past the time frame where thrombolytic therapy is effective.